NCT05417867View on ClinicalTrials.gov

Evaluating the Association Between Changes in the Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer

RecruitingOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

April 14, 2021

Primary Completion Date

September 30, 2025

Study Completion Date

March 31, 2026

Conditions
Chemotherapy-Related Nausea and/or VomitingEarly Stage Breast CarcinomaAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of stool and blood samples

OTHER

Questionnaire Administration

Complete questionnaires

Trial Locations (5)

55905

SUSPENDED

Mayo Clinic in Rochester, Rochester

56001

RECRUITING

Mayo Clinic Health System in Mankato, Mankato

56007

RECRUITING

Mayo Clinic Health System in Albert Lea, Albert Lea

85259

SUSPENDED

Mayo Clinic in Arizona, Scottsdale

32224-9980

ACTIVE_NOT_RECRUITING

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05417867 - Evaluating the Association Between Changes in the Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer | Biotech Hunter | Biotech Hunter